The Israeli startup just secured major funding to help companies stop wasting money on inefficient AI computing. For Indian enterprises scaling their AI ambitions, this signals a shift from building AI models to managing what runs them.
Author: Neelesh Pednekar
Mantis Biotech Bets on Virtual Patients to Fix Medicine’s Data Problem
The startup is building AI-powered “digital twins” of human biology to generate synthetic patient data for drug development. For healthcare leaders, this could mean faster trials, lower costs, and a new way to test treatments before they reach real patients.
Mistral AI’s $830M Debt Raise Signals Europe’s Bid to Own Its AI Infrastructure
The French AI company’s massive debt financing isn’t just about building models — it’s about building data centers. For Indian technology leaders, this move reshapes where and how they’ll access AI compute in the coming years.